Neurological Diseases: Cause and Effect in the Era of COVID-19 | ||
| SVU-International Journal of Medical Sciences | ||
| Article 4, Volume 4, Issue 2, July 2021, Pages 25-37 PDF (358.71 K) | ||
| Document Type: Reviews Articles. | ||
| DOI: 10.21608/svuijm.2021.63964.1094 | ||
| Authors | ||
| Islam Elmalky* 1; Eptehal Dongol2; Hazem Abdelkhalek3 | ||
| 1Department of Neurology, Faculty of Medicine, South Valley University, Qena, Egypt. | ||
| 2Department of Chest Disease, Faculty of Medicine, South Valley University, Qena, Egypt. | ||
| 3Department of Neuropsychiatry, Faculty of Medicine, Tanta University, Tanta, Egypt. | ||
| Abstract | ||
| Background: SARS-CoV-2 new infectious disease was first reported in Wuhan, China in December 2019. Thereafter, it has extensively spread causing global pandemic. It was named as corona virus disease 2019 (COVID-19) by WHO in February 2020. Other than the well described COVID-19 respiratory and cardiac manifestations, the neurological manifestations are not that uncommon. Objectives: In this review, we are trying to shed light on this pandemic disease and its neurological presentation, which might enable neurologists to pick up and promptly deal with such cases. The COVID-19 neurological presentation can include many diverse symptoms and rapid clinical deterioration can be related to development of neurological affection. Moreover, the patients with already neurological diseases, when affected by the COVID-19 showed worse prognosis. Conclusion: Enhanced research is needed to illustrate and explain and hence development and tailoring adjusted treatment for the neurological manifestation for better management of such cases to improve the outcome. | ||
| Keywords | ||
| COVID-19; Neurological diseases; Corona Virus; Peripheral Nervous System; Central Nervous System | ||
|
Statistics Article View: 331 PDF Download: 341 |
||
